SLC2A1 and neoplasm: Several small molecules that inhibit GLUT1 have been shown to selectively kill cancer cells in vitro.59,60 In our study, genetic knockdown of GLUT1 or chemical inhibition of GLUT1 activity suppressed cell viability and tumor progression both in vitro and in vivo.